Cargando…
Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report
ALZET(®) osmotic pumps are implantable devices used in animals for the continuous infusion of drugs or proteins at controlled rates from 1 day to 4 weeks. Pumps have been used successfully in a number of studies on the effects of controlled delivery of a wide range of experimental agents, independen...
Autor principal: | JANKUN, JERZY |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501414/ https://www.ncbi.nlm.nih.gov/pubmed/23170122 http://dx.doi.org/10.3892/etm.2012.639 |
Ejemplares similares
-
Application of Long-Acting VLHL PAI-1 during Sutureless Partial Nephrectomy in Mice Reduces Bleeding
por: Shahrour, Khaled, et al.
Publicado: (2015) -
Can components of the plasminogen activation system predict the outcome of kidney transplants?
por: Jankun, Jerzy, et al.
Publicado: (2018) -
Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
por: Gondek, Tomasz, et al.
Publicado: (2014) -
Osmotic Pump Drug Delivery Systems—A Comprehensive Review
por: Almoshari, Yosif
Publicado: (2022) -
Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac
por: Dasankoppa, Fatima Sanjeri, et al.
Publicado: (2012)